Literature DB >> 29237797

Endothelial progenitor cells enhance blood-brain barrier permeability in subacute stroke.

João Sargento-Freitas1, Sezin Aday1, César Nunes1, Miguel Cordeiro1, Ana Gouveia1, Fernando Silva1, Cristina Machado1, Bruno Rodrigues1, Gustavo Cordeiro Santo1, Carlos Ferreira1, André Amorim1, Susana Sousa1, Ana Catarina Gomes1, Miguel Castelo-Branco1, Lino Ferreira2, Luís Cunha2.   

Abstract

OBJECTIVE: To study the association among endothelial progenitor cells (EPCs), subacute blood-brain barrier (BBB) permeability, and clinical outcome after ischemic stroke, determining the micro RNAs of EPCs responsible for good clinical outcome.
METHODS: We included consecutive patients with nonlacunar acute ischemic strokes in the territory of a middle cerebral artery and ages between 18 and 80 years. Clinical outcome was defined as modified Rankin Scale score at 3 months. Neuroimaging was performed at day 0 and 7 by MRI, including assessment of BBB permeability by dynamic contrast enhancement. EPCs were isolated from peripheral venous blood, quantified, and submitted to in vitro functional tests, including migratory and angiogenic assays. Stroke hemodynamics were evaluated serially by ultrasound. Statistical significance was set at p < 0.05.
RESULTS: We included 45 patients; mean age was 70.0 ± 10.0 years. The in vitro functional properties of EPCs were associated with BBB permeability, particularly at day 7. The number of each EPC subset at both timepoints was not associated with BBB permeability. Permeability of BBB at day 7 was independently associated with improved clinical outcome (odds ratio 0.897; 95% confidence interval 0.816-0.986; p = 0.025). The EPCs (CD34+ cell subset) of patients with good clinical outcome showed 24 differentially expressed miRNAs, with a common effect on adherens junction pathway.
CONCLUSIONS: The functional properties of EPCs are associated with enhanced subacute permeability of BBB and improved clinical outcome after acute ischemic stroke.
Copyright © 2017 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29237797     DOI: 10.1212/WNL.0000000000004801

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  Protein kinase C-β distinctly regulates blood-brain barrier-forming capacity of Brain Microvascular endothelial cells and outgrowth endothelial cells.

Authors:  Rais Reskiawan A Kadir; Mansour Alwjwaj; Ulvi Bayraktutan
Journal:  Metab Brain Dis       Date:  2022-06-28       Impact factor: 3.655

2.  Correlation of serum uric acid, cystatin C and high-sensitivity C-reactive protein with cognitive impairment in lacunar cerebral infarction.

Authors:  Fenfei Wanggong; Jianfeng Xiang; Shichen Yang; Weilan Zhang; Reziya Tuerganbieke
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 3.  Borneol for Regulating the Permeability of the Blood-Brain Barrier in Experimental Ischemic Stroke: Preclinical Evidence and Possible Mechanism.

Authors:  Zi-Xian Chen; Qing-Qing Xu; Chun-Shuo Shan; Yi-Hua Shi; Yong Wang; Raymond Chuen-Chung Chang; Guo-Qing Zheng
Journal:  Oxid Med Cell Longev       Date:  2019-02-04       Impact factor: 6.543

4.  Permeability of the blood-brain barrier through the phases of ischaemic stroke and relation with clinical outcome: protocol for a systematic review.

Authors:  Sara Bernardo-Castro; Helena Donato; Lino Ferreira; João Sargento-Freitas
Journal:  BMJ Open       Date:  2020-09-18       Impact factor: 2.692

Review 5.  Pathophysiology of Blood-Brain Barrier Permeability Throughout the Different Stages of Ischemic Stroke and Its Implication on Hemorrhagic Transformation and Recovery.

Authors:  Sara Bernardo-Castro; João André Sousa; Ana Brás; Carla Cecília; Bruno Rodrigues; Luciano Almendra; Cristina Machado; Gustavo Santo; Fernando Silva; Lino Ferreira; Isabel Santana; João Sargento-Freitas
Journal:  Front Neurol       Date:  2020-12-09       Impact factor: 4.003

Review 6.  Unraveling the potential of endothelial progenitor cells as a treatment following ischemic stroke.

Authors:  Antía Custodia; Alberto Ouro; João Sargento-Freitas; Marta Aramburu-Núñez; Juan Manuel Pías-Peleteiro; Pablo Hervella; Anna Rosell; Lino Ferreira; José Castillo; Daniel Romaus-Sanjurjo; Tomás Sobrino
Journal:  Front Neurol       Date:  2022-09-08       Impact factor: 4.086

7.  STROKE34 Study Protocol: A Randomized Controlled Phase IIa Trial of Intra-Arterial CD34+ Cells in Acute Ischemic Stroke.

Authors:  João Sargento-Freitas; Anabela Pereira; André Gomes; Paula Amorim; Teresa Matos; Carla M P Cardoso; Fernando Silva; Gustavo Cordeiro Santo; César Nunes; Orlando Galego; José Carda; João Branco; Víctor Lourenço; Luís Cunha; Lino Ferreira
Journal:  Front Neurol       Date:  2018-05-07       Impact factor: 4.003

8.  The Effects and Underlying Mechanisms of Cell Therapy on Blood-Brain Barrier Integrity After Ischemic Stroke.

Authors:  Li Gao; Zhenghong Song; Jianhua Mi; Pinpin Hou; Chong Xie; Jianquan Shi; Yansheng Li; Anatol Manaenko
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

Review 9.  Therapeutic Nanoparticles for the Different Phases of Ischemic Stroke.

Authors:  Sara Bernardo-Castro; Inês Albino; Ángela María Barrera-Sandoval; Francesca Tomatis; João André Sousa; Emanuel Martins; Susana Simões; Miguel M Lino; Lino Ferreira; João Sargento-Freitas
Journal:  Life (Basel)       Date:  2021-05-26

Review 10.  Non-coding RNAs: the extensive and interactive regulators of the blood-brain barrier permeability.

Authors:  Ruicheng Yang; Bojie Xu; Bo Yang; Jiyang Fu; Huanchun Chen; Xiangru Wang
Journal:  RNA Biol       Date:  2021-07-20       Impact factor: 4.652

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.